PFIZER INC: $1.1B Department of Health and Human Services Contract Vehicle
Summary
Pfizer Inc receives a $1.1B contract from the CDC, providing a meaningful 1.85% revenue boost to a company facing declining post-COVID sales. This award supports Pfizer's healthcare segment and stabilizes its financial outlook.
See which stocks are affected
Key takeaways, market implications, full AI analysis, and connected signals are available to HillSignal members.
Already have an account? Log in
Key Takeaways
- 1.$1.1B CDC contract provides ~1.85% revenue boost to Pfizer
- 2.Contract stabilizes Pfizer's declining post-COVID revenue
- 3.No direct legislative authorization, but aligns with public health spending
Market Implications
This contract provides a modest but meaningful revenue boost to Pfizer, which has been struggling with declining sales after the COVID-19 pandemic. The award could help stabilize investor sentiment and support the stock price in the near term. However, given the contract's size relative to Pfizer's overall revenue, it is not a transformative catalyst. Investors should monitor for additional CDC contracts or broader public health funding that could further benefit Pfizer.
Full Analysis
- The contract: Pfizer Inc has been awarded a $1.1B indefinite delivery/indefinite quantity contract by the Centers for Disease Control and Prevention (CDC), under the Department of Health and Human Services. The contract period runs from April 2025 to March 2026, and the description 'END OF PWS' suggests it is a continuation or final phase of a prior statement of work, likely for vaccines or medical countermeasures. 2) The public company beneficiary: Pfizer Inc is the direct recipient. With FY2025 revenue of $59.6B, this $1.1B award represents about 1.85% of annual revenue—a significant but not transformative boost. Given Pfizer's net income of $2.1B and net margin of 3.56%, this contract could add roughly $39M to net income (assuming similar margins), improving profitability. 3) Connection to legislation: No related bill signals directly authorize this contract, but it aligns with ongoing public health funding through HHS appropriations. The contract may be part of broader pandemic preparedness or routine vaccine programs. 4) Supply chain winners: Key suppliers to Pfizer include contract manufacturing organizations (CMOs) like Thermo Fisher Scientific ($TMO) for biologics production, and raw material suppliers like Merck KGaA (private) or Lonza Group (private). Smaller-cap suppliers such as BioNTech ($BNTX) could benefit if the contract involves mRNA technology, though Pfizer's supply chain is diversified. 5) Historical pattern: Similar CDC contracts for vaccine procurement have historically provided stable, recurring revenue for pharmaceutical companies. For example, prior CDC contracts with Pfizer for Prevnar or COVID-19 vaccines have supported consistent cash flows. This award likely signals continued government investment in infectious disease prevention, which is a tailwind for vaccine developers.
Connected Signals
Matched on shared policy language across AI analyses, with ticker & timing weight
PFIZER INC: $661M Department of Health and Human Services Contract Vehicle
PFIZER INC: $45.5M Department of Health and Human Services Contract Vehicle
PFIZER INC: $45.5M Department of Health and Human Services Contract Vehicle
GLAXOSMITHKLINE, LLC: $10.4M Department of Health and Human Services Contract Vehicle
Related Presidential Actions
Executive orders & memoranda affecting the same sectors or companies
Advancing Women's Health to Improve Outcomes in All Phases of Life
This executive order establishes a Women's Health Division within the NIH to coordinate and accelerate research on understudied women's health conditions, and creates a White House Women's Health Task Force to drive policy reforms and translation of research into clinical practice across federal agencies. It directs specific agencies to prioritize research, data collection, and translation into prevention, diagnosis, and treatment, with a focus on all life stages from infancy through aging.
Enhancing Program Integrity and Integrity and Interagency Coordination in the Administration of the H-1B Nonimmigrant Visa Program
This executive order directs the Secretaries of State, Labor, and Homeland Security to coordinate with Commerce, Education, and the SBA when processing H-1B petitions, and requires them to consider whether the employer has engaged in layoffs of similarly situated U.S. workers within the past year. It also orders the Labor Department to review past labor condition applications for potential enforcement actions against sponsoring employers, effectively tightening scrutiny on H-1B usage, especially by outsourcing firms.
Accelerating Access To Veterans' Benefits And Employment Opportunities
This proclamation orders the Secretaries of War and Veterans Affairs to mandate rapid, ongoing digital sharing of military personnel and medical records, deploy AI-powered tools for benefits applications, and update existing IT contracts for interoperability. It also requires the Transition Assistance Program to connect separating service members to specific jobs or training programs before discharge.
Contract Details
Recipient
PFIZER INC
Award Amount
$1,123,734,612
Awarding Agency
Department of Health and Human Services
Sub-Agency
Centers for Disease Control and Prevention
Contract Type
INDEFINITE DELIVERY / INDEFINITE QUANTITY
Free — no credit card
Get the next market-moving signal before the news does
HillSignal scores every Congressional bill, federal contract, and insider filing for market impact and emails you the high-conviction ones — free, no credit card.
Weekly digest — the congressional activity that actually moved markets that week, in plain English. Free, one email.
Free forever plan · No credit card · Unsubscribe in one click
Want the live terminal too? Create a free account →